Fangda advised Shanghai Henlius Biotech, Inc. on the deal.Shanghai Henlius Biotech, Inc. (“Henlius”, 2696.HK) secured a collaboration and license agreement with Palleon Pharmaceuticals (“Palleon”) to develop…
Shanghai Henlius Biotech’s Collaboration and License Agreement with Palleon Pharmaceuticals
![](https://globallegalchronicle.com/wp-content/uploads/2025/01/shanghai-henlius-biotechs-collaboration-and-license-agreement-with-palleon-pharmaceuticals_679a03af9bb1f.jpeg)